Skip to Content
Hae Menu

SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer

Hear Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, presents the updated results of treatment with trastuzumab deruxtecan in patients with HER2 positive metastatic breast cancer.

Avaa artikkeli

Jos olet lääkäri, sairaanhoitaja tai muu terveydenhuollon ammattilainen, voit käyttää koko artikkelia luomalla profiilin BestPractice Nordic -sivustolle.

Related

Falling living standards during the COVID-19 crisis

/ Ahmed Mushfiq Mobarak
Covid-19 Play the Video 10:17

Management of Erdafitinib, a pan-FGFR kinase inhibitor, treatment-emergent adverse events

/ Arlene O. Siefker-Radtke
ASCO GU21 Play the Video 4:47

Patient-reported outcomes of patients with advanced renal cell carcinoma treated with first-line nivolumab plus cabozantinib

/ David Cella
ASCO GU21 Play the Video 6:17
Back to top